Multiscale prediction of patient-specific platelet function under flow

Blood

Volumn 120, Issue 1, 2012, Pages 190-198

  Flamm, Matthew H ^a   Colace, Thomas V ^a   Chatterjee, Manash S ^a   Jing, Huiyan ^a   Zhou, Songtao ^a   Jaeger, Daniel ^a   Brass, Lawrence F ^b   Sinno, Talid ^a   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; CONVULXIN; ILOPROST; INDOMETACIN; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR;

ARTICLE; BLOOD; BLOOD FLOW; CONTROLLED STUDY; DRUG RESPONSE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MICROFLUIDIC ANALYSIS; MONTE CARLO METHOD; NERVE CELL NETWORK; NORMAL HUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHEAR RATE; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION;

EID: 84863572555     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-388140     Document Type: Article

References (45)

1. Frossard M, Fuchs I, Leitner JM, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation. 2004;110(11):1392-1397. (Pubitemid 39238016)
2. Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF. Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost. 2006;4(9):2043-2050. (Pubitemid 44226787)
3. Hetherington SL, Singh RK, Lodwick D, Thompson JR, Goodall AH, Samani NJ. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol. 2005;25(1):252- 257.
4. Bray PF. Platelet hyperreactivity: predictive and intrinsic properties. Hematol Oncol Clin North Am. 2007;21(4):633-645. (Pubitemid 47102557)
5. Wei AH, Schoenwaelder SM, Andrews RK, Jackson SP. New insights into the haemostatic function of platelets. Br J Haematol. 2009;147(4): 415-430.
6. Sandrock K, Zieger B. Current strategies in diagnosis of inherited storage pool defects. Transfus Med Hemother. 2010;37(5):248-258.
7. García Rodríguez LA, Lin KJ, Hernandez-Diaz S, Johansson S. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation. 2011;123(10):1108-1115.
8. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987;69(2):625-628. (Pubitemid 17022038)
9. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986;78(6):1456-1461. (Pubitemid 17219507)
10. Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res. 2007; 120(suppl 1):S5-S9. (Pubitemid 46874544)
11. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117(11): 1449-1459. (Pubitemid 351501497)
12. van Schie MC, van Loon JE, de Maat MPM, Leebeek FWG. Genetic determinants of von Willebrand Factor levels and activity in relation to the risk of cardiovascular disease. A review. J Thromb Haemost. 2011;9(5):899-908.
13. Schneider SW, Nuschele S, Wixforth A, et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A. 2007;104(19):7899-7903. (Pubitemid 47185848)
14. Dayananda KM, Singh I, Mondal N, Neelamegham S. von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation. Blood. 2010; 116(19):3990-3998.
15. Gao W, Anderson PJ, Majerus EM, Tuley EA, Sadler JE. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci U S A. 2006;103(50): 19099-19104. (Pubitemid 350002834)
16. Doggett TA, Girdhar G, Lawshe A, et al. Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond. Biophys J. 2002;83(1):194-205. (Pubitemid 34694731)
17. Doggett TA, Girdhar G, Lawshe A, et al. Alterations in the intrinsic properties of the GPIbalp- VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Blood. 2003;102(1):152-160. (Pubitemid 36759649)
18. Tilles AW, Eckstein EC. The near-wall excess of platelet-sized particles in blood flow: its dependence on hematocrit and wall shear rate. Microvasc Res. 1987;33(2):211-223. (Pubitemid 17065260)
19. Eckstein EC, Belgacem F. Model of platelet transport in flowing blood with drift and diffusion terms. Biophys J. 1991;60(1):53-69.
20. Kuharsky AL, Fogelson AL. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J. 2001;80(3):1050-1074. (Pubitemid 32182136)
21. Leiderman K, Fogelson AL. Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow. Math Med Biol. 2011;28(1):47-84.
22. Chatterjee MS, Purvis JE, Brass LF, Diamond SL. Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat Biotechnol. 2010;28(7):727-732.
23. Maloney SF, Brass LF, Diamond SL. P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr Biol (Camb). 2010;2(4):183-192.
24. Mumford AD, Dawood BB, Daly ME, et al. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis. Blood. 2010;115(2):363-369.
25. Turitto VT, Benis AM, Leonard EF. Platelet diffusion in flowing blood. Indust Eng Chem Fund. 1972;11(2):216-223.
26. Flamm MH, Diamond SL, Sinno T. Lattice kinetic Monte Carlo simulations of convective-diffusive systems. J Chem Phys. 2009;130(9):094904.
27. Flamm MH, Sinno T, Diamond SL. Simulation of aggregating particles in complex flows by the lattice kinetic Monte Carlo method. J Chem Phys. 2011;134(3):034905.
28. Yeh CJ, Calvez AC, Eckstein EC. An estimated shape function for drift in a platelet-transport model. Biophys J. 1994;67(3):1252-1259. (Pubitemid 24272979)
29. Bell GI. Models for specific adhesion of cells to cells. Science. 1978;200(4342):618-627.
30. Nanne EE, Aucoin CP, Leonard EF. Shear rate and hematocrit effects on the apparent diffusivity of urea in suspensions of bovine erythrocytes. ASAIO J. 2010;56(3):151-156.
31. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol. 1999;276(1 Pt 1):C267-C278. (Pubitemid 29063590)
32. Holmsen H, Storm E, James Day H. Determination of ATP and ADP in blood platelets: A modification of the firefly luciferase assay for plasma. Anal Biochem. 1972;46(2):489-501.
33. De Caterina R, Giannessi D, Gazzetti P, Bernini W. Thromboxane-B2 generation during ex-vivo platelet aggregation. J Nucl Med Allied Sci. 1984; 28(3):185-196. (Pubitemid 15159093)
34. Hubbell JA, McIntire LV. Platelet active concentration profiles near growing thrombi - a mathematical consideration. Biophys J. 1986;50(5): 937-945.
35. Colace T, Falls E, Zheng X, Diamond SL. Analysis of morphology of platelet aggregates formed on collagen under laminar blood flow. Ann Biomed Eng. 2011;39(2):922-929.
36. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood. 1993;82(2):505-512. (Pubitemid 23206114)
37. Hollopeter G, Jantzen H-M, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001;409(6817): 202-207. (Pubitemid 32144286)
38. Srinivasan S, Mir F, Huang J-S, Khasawneh FT, Lam SCT, Le Breton GC. The P2Y12 antagonists, 2-methylthioadenosine 5′-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP Levels. J Biol Chem. 2009;284(24):16108- 16117.
39. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol. 2010;6(9): e1000950.
40. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem. 2002;277(21):18322-18333. (Pubitemid 34952376)
41. Pivkin IV, Richardson PD, Karniadakis G. Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi. Proc Natl Acad Sci U S A. 2006;103(46):17164-17169. (Pubitemid 44788940)
42. Xu Z, Lioi J, Mu J, et al. A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascade. Biophys J. 2010;98(9):1723-1732.
43. Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111(7):3507-3513.
44. Mody NA, King MR. Platelet Adhesive Dynamics. Part II: High shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging. Biophys J. 2008;95(5):2556-2574.
45. Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S. Arg60 to Leu mutation of the human TXA2 receptor in a dominantly inherited bleeding disorder. J Clin Invest. 1994;94(4):1662-1667.